This inventor holds 1 USPTO granted patent. Top assignee: Ucbbiopharma Srl. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thierry Demaude: Innovator in Pharmaceutical Chemistry
Introduction
Thierry Demaude is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various medical disorders.
Latest Patents
Demaude holds a patent for dihydro-cyclopenta-isoquinoline sulfonamides derivatives. This invention relates to dihydro-cyclopenta-isoquinoline derivatives of a specific formula, along with processes for preparing them. The pharmaceutical compositions containing these derivatives are utilized in treating disorders caused by IgE, including allergic responses and certain autoimmune responses. His work is particularly focused on disorders linked to the interaction of IgE with the FcεRI receptor.
Career Highlights
Thierry Demaude is associated with UCB Biopharma Srl, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in the field has led to advancements that benefit patients suffering from various conditions.
Collaborations
Demaude has collaborated with notable colleagues, including Timothy John Norman and Zhaoning Zhu. Their combined efforts in research and development have furthered the understanding and application of his patented inventions.
Conclusion
Thierry Demaude's work exemplifies the impact of innovation in pharmaceutical chemistry. His contributions through patents and collaborations continue to advance medical science and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile